

1,402,507 filings since 2004 · latest accepted Nov 4, 2026, 5:30 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Nov 27, 2018 accepted 2:18 PM ET | CLDXCelldex Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jun 1, 2018 accepted 12:00 PM ET | CLDXCelldex Therapeutics, Inc. | 3.01Delisting notice |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
Apr 24, 2018 accepted 8:01 PM ET | CLDXCelldex Therapeutics, Inc. | 2.05Restructuring costs | DocumentSEC ↗ |
May 20, 2013 accepted 12:25 PM ET | CLDXCelldex Therapeutics, Inc. | 1.02Agreement terminated | DocumentSEC ↗ |
Apr 3, 2012 accepted 8:30 PM ET | CLDXCelldex Therapeutics, Inc. | 1.02Agreement terminated | DocumentSEC ↗ |
Sep 7, 2010 accepted 8:28 PM ET | CLDXCelldex Therapeutics, Inc. | 1.02Agreement terminated | DocumentSEC ↗ |
Jun 9, 2008 accepted 8:28 PM ET | CLDXCelldex Therapeutics, Inc. | 4.01Auditor change | DocumentSEC ↗ |
Mar 11, 2008 accepted 9:26 PM ET | CLDXCelldex Therapeutics, Inc. | 2.01Acquisition / disposition3.01Delisting notice3.03Holder rights modified5.01Change in control5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Jan 9, 2008 accepted 10:29 PM ET | CLDXCelldex Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Aug 30, 2007 accepted 12:30 PM ET | CLDXCelldex Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Aug 21, 2007 accepted 12:00 PM ET | CLDXCelldex Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Jul 10, 2007 accepted 9:00 PM ET | CLDXCelldex Therapeutics, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Apr 16, 2007 accepted 12:30 PM ET | CLDXCelldex Therapeutics, Inc. | 2.05Restructuring costs | DocumentSEC ↗ |